ŠÖ“Œ˜A‡ŽY‰È•wl‰ÈŠw‰ï
‰ïˆõƒƒOƒCƒ“ ‘ã•\ˆ¥ŽA
‘‰ïEŠwpW‰ï
Šw‰ïŽ
’芼
Œö
—˜‰v‘Š”½
–ðˆõ\¬
Ž––±‹ÇˆÄ“à
‹lŽ{Ýˆê——
ŠÖ˜AƒŠƒ“ƒN

@ŠÖ“Œ˜A‡ŽY‰È•wl‰ÈŠw‰ï‰ïŽ ƒIƒ“ƒ‰ƒCƒ“ƒWƒƒ[ƒiƒ‹

<< Šw‰ïŽ‚Ö–ß‚é
<< ‘O‚̃y[ƒW‚Ö–ß‚é

y“ÁWz
Ã‰ªŒ§“à‚Å”­Ç‚µ‚½—r…ÇðÇ‹^‚¢Ç—á‚̉ðÍi—r…ÇðÇ“o˜^Ž–‹Æj


‹e’r@‘ì, –Ø‘º@‘, ‹v•Û@ˆ¤Žq, •½ˆä@‹v–ç, ‰Í‘º@—²ˆê, ‘åˆä@‹ˆê, ™Œ´@ˆêœA, ™‘º@Šî, ‹àŽR@®—T
•l¼ˆã‰È‘åŠwŽüŽY•êŽqƒZƒ“ƒ^[


Key wordsFamniotic fluid embolism, Zinc coproporphyrin I, Sialyl TN (STN), C3/C4, Interleukin8 (IL-8)

“ú–{ŽY‰È•wl‰ÈŠw‰ïŠÖ“Œ˜A‡’n•û•”‰ï‰ïŽ, 45(1) 31-36, 2008


ˆê”ÊŽÐ’c–@lŠÖ“Œ˜A‡ŽY‰È•wl‰ÈŠw‰ïŽ––±‹Ç@§102-0083 “Œ‹ž“sç‘ã“c‹æ’¬4-7 ’¬ƒp[ƒNƒTƒCƒhƒrƒ‹402 Š”)MAƒRƒ“ƒxƒ“ƒVƒ‡ƒ“ƒRƒ“ƒTƒ‹ƒeƒBƒ“ƒO“à
TELF03-3288-0993@FAXF03-5275-1192@E-mailFkantorengo@jsog-k.jp
Copyright (C) ˆê”ÊŽÐ’c–@lŠÖ“Œ˜A‡ŽY‰È•wl‰ÈŠw‰ï